trending Market Intelligence /marketintelligence/en/news-insights/trending/oz8K7qgUqKemjBvVhP9-vA2 content esgSubNav
In This List

Safal Herbs fiscal Q3 profit climbs 68.4% YOY

Blog

Industries Most and Least Impacted by COVID-19: A Market-Implied Probability of Default Perspective

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection

Video

S&P Capital IQ Pro | Powered by Advanced Visualization


Safal Herbs fiscal Q3 profit climbs 68.4% YOY

Safal Herbs Ltd. said its normalized net income for the fiscal third quarter ended Dec. 31, 2015, was 20,000 rupees, a gain of 68.4% from 11,880 rupees in the prior-year period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

The normalized profit margin climbed to 0.9% from 0.6% in the year-earlier period.

Total revenue climbed 10.0% on an annual basis to 2.3 million rupees from 2.1 million rupees, and total operating expenses rose 9.4% from the prior-year period to 2.2 million rupees from 2.0 million rupees.

Reported net income came to 32,000 rupees, compared with 19,000 rupees, or 0 paise per share, in the prior-year period.

As of Feb. 12, US$1 was equivalent to 68.19 Indian rupees.